BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33110077)

  • 1. A protein tertiary structure mimetic modulator of the Hippo signalling pathway.
    Adihou H; Gopalakrishnan R; Förster T; Guéret SM; Gasper R; Geschwindner S; Carrillo García C; Karatas H; Pobbati AV; Vazquez-Chantada M; Davey P; Wassvik CM; Pang JKS; Soh BS; Hong W; Chiarparin E; Schade D; Plowright AT; Valeur E; Lemurell M; Grossmann TN; Waldmann H
    Nat Commun; 2020 Oct; 11(1):5425. PubMed ID: 33110077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Hippo Pathway Transcription Factor TEAD.
    Lin KC; Park HW; Guan KL
    Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Transcriptional Enhanced Associate Domains (TEADs).
    Gibault F; Sturbaut M; Bailly F; Melnyk P; Cotelle P
    J Med Chem; 2018 Jun; 61(12):5057-5072. PubMed ID: 29251924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
    Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
    Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway.
    Chan P; Han X; Zheng B; DeRan M; Yu J; Jarugumilli GK; Deng H; Pan D; Luo X; Wu X
    Nat Chem Biol; 2016 Apr; 12(4):282-9. PubMed ID: 26900866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
    Sudol M
    Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of IRF-3 activation by phosphorylation.
    Yoneyama M; Suhara W; Fujita T
    J Interferon Cytokine Res; 2002 Jan; 22(1):73-6. PubMed ID: 11846977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progresses on the molecular structure of the Hippo signaling pathway components.
    Hu LQ; Zhou ZC; Tian W
    Yi Chuan; 2017 Jul; 39(7):659-674. PubMed ID: 28757480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The surprising features of the TEAD4-Vgll1 protein-protein interaction.
    Mesrouze Y; Hau JC; Erdmann D; Zimmermann C; Fontana P; Schmelzle T; Chène P
    Chembiochem; 2014 Mar; 15(4):537-42. PubMed ID: 24504694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie.
    Sun X; Ding Y; Zhan M; Li Y; Gao D; Wang G; Gao Y; Li Y; Wu S; Lu L; Liu Q; Zhou Z
    Nat Commun; 2019 Jan; 10(1):411. PubMed ID: 30679505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function.
    Watt KI; Goodman CA; Hornberger TA; Gregorevic P
    Exerc Sport Sci Rev; 2018 Apr; 46(2):92-96. PubMed ID: 29346163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors.
    Hagenbeek TJ; Webster JD; Kljavin NM; Chang MT; Pham T; Lee HJ; Klijn C; Cai AG; Totpal K; Ravishankar B; Yang N; Lee DH; Walsh KB; Hatzivassiliou G; de la Cruz CC; Gould SE; Wu X; Lee WP; Yang S; Zhang Z; Gu Q; Ji Q; Jackson EL; Lim DS; Dey A
    Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the SPRY domain of human Ash2L and its interactions with RbBP5 and DPY30.
    Chen Y; Cao F; Wan B; Dou Y; Lei M
    Cell Res; 2012 Mar; 22(3):598-602. PubMed ID: 22231628
    [No Abstract]   [Full Text] [Related]  

  • 14. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
    Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
    Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the Hippo pathway? Is the Hippo pathway conserved in Caenorhabditis elegans?
    Yang Z; Hata Y
    J Biochem; 2013 Sep; 154(3):207-9. PubMed ID: 23843471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes.
    Pobbati AV; Chan SW; Lee I; Song H; Hong W
    Structure; 2012 Jul; 20(7):1135-40. PubMed ID: 22632831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
    Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
    J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
    Wang Z; Benoit G; Liu J; Prasad S; Aarnisalo P; Liu X; Xu H; Walker NP; Perlmann T
    Nature; 2003 May; 423(6939):555-60. PubMed ID: 12774125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.
    Pobbati AV; Han X; Hung AW; Weiguang S; Huda N; Chen GY; Kang C; Chia CS; Luo X; Hong W; Poulsen A
    Structure; 2015 Nov; 23(11):2076-86. PubMed ID: 26592798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of a TBP-TAF(II)230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP.
    Liu D; Ishima R; Tong KI; Bagby S; Kokubo T; Muhandiram DR; Kay LE; Nakatani Y; Ikura M
    Cell; 1998 Sep; 94(5):573-83. PubMed ID: 9741622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.